Skip to main content
logo
Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
104.79
-4.90 (-4.47%)
Aug 20, 2026, 4:00 PM EDT - Market closed

Oruka Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Market Capitalization
6,9331,467679
Market Cap Growth
1113.89%116.22%-
Enterprise Value
5,810971325
Last Close Price
109.6930.3119.39

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
PB Ratio
6.033.111.78
P/TBV Ratio
6.363.131.79

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Debt / Equity Ratio
0.000.000.00
Net Debt / Equity Ratio
-1.01-1.01-1.03
Net Debt / EBITDA Ratio
7.253.924.12
Net Debt / FCF Ratio
11.105.406.20
Quick Ratio
38.0321.9228.80
Current Ratio
38.5122.3728.89
Return on Equity (ROE)
-18.23%-24.69%-
Return on Assets (ROA)
-12.95%-17.25%-
Return on Capital Employed (ROCE)
-13.90%-25.80%-24.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Earnings Yield
-1.55%-7.19%-13.46%
FCF Yield
-1.43%-6.03%-9.33%
Buyback Yield / Dilution
-49.96%-171.69%-
SEC Filings: 10-K · 10-Q